Growth Metrics

Vertex Pharmaceuticals (VRTX) Shareholder's Equity (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Revolution Medicines 31.20 Bn 31.20 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.73%
Dec 31, 2025 7.78%
Sep 30, 2025 0.83%
Jun 30, 2025 4.12%
Mar 31, 2025 0.53%
Dec 31, 2024 4.98%
Sep 30, 2024 5.80%
Jun 30, 2024 -20.34%
Mar 31, 2024 5.50%
Dec 31, 2023 6.47%
Sep 30, 2023 6.74%
Jun 30, 2023 7.19%
Mar 31, 2023 3.73%
Dec 31, 2022 6.78%
Sep 30, 2022 9.19%
Jun 30, 2022 9.41%
Mar 31, 2022 7.99%
Dec 31, 2021 5.97%
Sep 30, 2021 3.64%
Jun 30, 2021 2.41%
Mar 31, 2021 3.38%
Dec 31, 2020 6.80%
Sep 30, 2020 8.17%
Jun 30, 2020 16.37%
Mar 31, 2020 6.19%
Dec 31, 2019 15.83%
Sep 30, 2019 3.62%
Jun 30, 2019 7.34%
Mar 31, 2019 6.50%
Dec 31, 2018 51.14%
Sep 30, 2018 8.09%
Jun 30, 2018 11.69%
Mar 31, 2018 19.02%
Dec 31, 2017 13.26%
Sep 30, 2017 -3.43%
Jun 30, 2017 10.96%
Mar 31, 2017 25.75%
Dec 31, 2016 10.75%
Sep 30, 2016 3.38%
Jun 30, 2016 4.72%
Mar 31, 2016 2.06%
Dec 31, 2015 1.57%
Sep 30, 2015 2.72%
Jun 30, 2015 5.08%
Mar 31, 2015 -9.00%
Dec 31, 2014 -5.17%
Sep 30, 2014 -1.40%
Jun 30, 2014 -4.76%
Mar 31, 2014 -9.25%
Dec 31, 2013 -6.26%
Sep 30, 2013 -4.13%
Jun 30, 2013 60.93%
Mar 31, 2013 -21.57%
Dec 31, 2012 -2.49%
Sep 30, 2012 1.72%
Jun 30, 2012 12.88%
Mar 31, 2012 15.04%
Dec 31, 2011 33.76%
Mar 31, 2011 -22.28%
Dec 31, 2010 -22.48%
Sep 30, 2010 -21.40%
Jun 30, 2010 -16.50%
Mar 31, 2010 -9.64%